Literature DB >> 9844051

Distribution of IgG subclasses in antimonial unresponsive Indian kala-azar patients.

M Chatterjee1, K Basu, D Basu, D Bannerjee, N Pramanik, S K Guha, R P Goswami, S K Saha, C Mandal.   

Abstract

Sodium antimony gluconate (SAG) is the mainstay of treatment for visceral leishmaniasis (VL) or kala-azar. In view of the increasing incidence of refractoriness to SAG in India, we compared the levels of parasite-specific IgG and IgG subclasses in 20 longitudinally followed up kala-azar patients. In both SAG-responsive (n = 10) and unresponsive patients (n = 10), the levels of total IgG, IgG1, IgG2, IgG3 and IgG4 were increased, the rank order being IgG1 > IgG2 > IgG3 = IgG4. Following treatment, a significant decrease in total IgG and the four subclasses occurred in the SAG-responsive group, whereas in the SAG-unresponsive group these levels were unchanged or slightly increased. Therefore, monitoring of IgG1 and IgG2 levels in Indian kala-azar patients is a good serologic alternative to monitoring the disease status.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9844051      PMCID: PMC1905139          DOI: 10.1046/j.1365-2249.1998.00752.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  35 in total

Review 1.  The interaction of Leishmania species with macrophages.

Authors:  J Alexander; D G Russell
Journal:  Adv Parasitol       Date:  1992       Impact factor: 3.870

2.  A rapid and simple diagnostic test for active visceral leishmaniasis.

Authors:  J M Scott; W G Shreffler; H W Ghalib; A el Asad; M Siddig; R Badaro; S G Reed
Journal:  Am J Trop Med Hyg       Date:  1991-03       Impact factor: 2.345

3.  Specificity of IgG subclass antibodies in different clinical manifestations of leprosy.

Authors:  S Dhandayuthapani; S Izumi; D Anandan; V N Bhatia
Journal:  Clin Exp Immunol       Date:  1992-05       Impact factor: 4.330

Review 4.  Immunology of leishmaniasis.

Authors:  F Y Liew; C A O'Donnell
Journal:  Adv Parasitol       Date:  1993       Impact factor: 3.870

5.  Determinants of the immune response in visceral leishmaniasis: evidence for predominance of endogenous interleukin 4 over interferon-gamma production.

Authors:  K Zwingenberger; G Harms; C Pedrosa; S Omena; B Sandkamp; S Neifer
Journal:  Clin Immunol Immunopathol       Date:  1990-11

6.  Interleukin 10 production correlates with pathology in human Leishmania donovani infections.

Authors:  H W Ghalib; M R Piuvezam; Y A Skeiky; M Siddig; F A Hashim; A M el-Hassan; D M Russo; S G Reed
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

7.  Immunobiological studies on experimental visceral leishmaniasis. II. Adherent cell-mediated down-regulation of delayed-type hypersensitivity response and up-regulation of B cell activation.

Authors:  S K Basak; B Saha; A Bhattacharya; S Roy
Journal:  Eur J Immunol       Date:  1992-08       Impact factor: 5.532

8.  Production of interferon gamma, interleukin 2, interleukin 4, and interleukin 10 by CD4+ lymphocytes in vivo during healing and progressive murine leishmaniasis.

Authors:  F P Heinzel; M D Sadick; S S Mutha; R M Locksley
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

9.  In vivo cytokine profiles in patients with kala-azar. Marked elevation of both interleukin-10 and interferon-gamma.

Authors:  C L Karp; S H el-Safi; T A Wynn; M M Satti; A M Kordofani; F A Hashim; M Hag-Ali; F A Neva; T B Nutman; D L Sacks
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

10.  Downregulation of Th1 cytokine production accompanies induction of Th2 responses by a parasitic helminth, Schistosoma mansoni.

Authors:  E J Pearce; P Caspar; J M Grzych; F A Lewis; A Sher
Journal:  J Exp Med       Date:  1991-01-01       Impact factor: 14.307

View more
  8 in total

1.  Identification of antibodies directed against O-acetylated sialic acids in visceral leishmaniasis: its diagnostic and prognostic role.

Authors:  M Chatterjee; V Sharma; C Mandal; S Sundar; S Sen
Journal:  Glycoconj J       Date:  1998-12       Impact factor: 2.916

2.  Coinfection of Leptomonas seymouri and Leishmania donovani in Indian leishmaniasis.

Authors:  Susmita Ghosh; Priyanka Banerjee; Avijit Sarkar; Simanti Datta; Mitali Chatterjee
Journal:  J Clin Microbiol       Date:  2012-05-23       Impact factor: 5.948

3.  Case series of misdiagnosis with rK39 strip test in Indian leishmaniasis.

Authors:  Nilay K Das; Sunny K Singh; Susmita Ghosh; Avijit Sarkar; Debanjan Mukhopadhyay; Susmita Roy; Dwijendra Nath Ganguly; Joyashree Nath Barbhuiya; Bibhuti Saha; Mitali Chatterjee
Journal:  Am J Trop Med Hyg       Date:  2011-05       Impact factor: 2.345

4.  Balance of IL-10 and interferon-gamma plasma levels in human visceral leishmaniasis: implications in the pathogenesis.

Authors:  Arlene Caldas; Cecília Favali; Dorlene Aquino; Vera Vinhas; Johan van Weyenbergh; Cláudia Brodskyn; Jackson Costa; Manoel Barral-Netto; Aldina Barral
Journal:  BMC Infect Dis       Date:  2005-12-19       Impact factor: 3.090

5.  IgG1 as a potential biomarker of post-chemotherapeutic relapse in visceral leishmaniasis, and adaptation to a rapid diagnostic test.

Authors:  Tapan Bhattacharyya; Armon Ayandeh; Andrew K Falconar; Shyam Sundar; Sayda El-Safi; Marissa A Gripenberg; Duncan E Bowes; Caroline Thunissen; Om Prakash Singh; Rajiv Kumar; Osman Ahmed; Osama Eisa; Alfarazdeg Saad; Sara Silva Pereira; Marleen Boelaert; Pascal Mertens; Michael A Miles
Journal:  PLoS Negl Trop Dis       Date:  2014-10-23

6.  An Insight Into Systemic Immune Response in Leishmania donovani Mediated Atypical Cutaneous Leishmaniasis in the New Endemic State of Himachal Pradesh, India.

Authors:  Lovlesh Thakur; Priyanka Madaan; Aklank Jain; Vinay Shankar; Ajeet Negi; Shashi Bhushan Chauhan; Shyam Sundar; Om Prakash Singh; Manju Jain
Journal:  Front Immunol       Date:  2022-01-04       Impact factor: 7.561

7.  IgG3 and IL10 are effective biomarkers for monitoring therapeutic effectiveness in Post Kala-Azar Dermal Leishmaniasis.

Authors:  Shilpa Sengupta; Mitali Chatterjee
Journal:  PLoS Negl Trop Dis       Date:  2021-11-10

8.  Molecular Tracking of the Leishmania Parasite.

Authors:  Srija Moulik; Shilpa Sengupta; Mitali Chatterjee
Journal:  Front Cell Infect Microbiol       Date:  2021-02-22       Impact factor: 5.293

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.